Skip to main content
DHG Pharma Recognized Among Vietnam’s Top 50 Best Performing Companies for the 15th Consecutive Year
12 November, 2026

DHG Pharma Recognized Among Vietnam’s Top 50 Best Performing Companies for the 15th Consecutive Year

DHG Pharma Recognized Among Vietnam’s Top 50 Best Performing Companies for the 15th Consecutive Year

On November 11 in Ho Chi Minh City, DHG Pharma was once again honored in the 2026 Top 50 Best Performing Companies in Vietnam ranking, organized by Nhip Cau Dau Tu Magazine in collaboration with Thien Viet Securities Joint Stock Company. This marks the 15th consecutive year that DHG Pharma has been included in this prestigious ranking (2012 - 2026).

The Top 50 ranking is a reputable annual assessment of corporate business performance, based on companies’ financial results over a consecutive three-year period. The evaluation considers key indicators, including revenue growth, return on equity (ROE), and earnings per share (EPS).

DHG Pharma’s recognition in the Top 50 for 15 consecutive years reflects the Company’s strong management capabilities, operational efficiency, and continued commitment to sustainable growth. It also further reinforces DHG Pharma’s position as one of Vietnam’s leading domestic pharmaceutical companies.

#DHGPharma #Vimotcuocsongkhoedephon

At the event, DHG Pharma was one of five companies to have maintained its position for 15 consecutive years, from 2012 to 2026.

Mr. Nguyen Thanh Binh represented the company in receiving the Top 50 Most Effective Businesses in Vietnam Award

                                                 DHG Pharma’s recognition in the Top 50 for 15 consecutive years reflects the Company’s strong management capabilities, operational efficiency, and continued commitment to sustainable growth.

Register an account - receive thousands of information

You will be one of the first to receive information, news, recruitment news... from DHG Pharmaceutical Joint-stock Company as soon as possible. Register today to enjoy thousands of incentives from DHG Pharmaceutical Joint-stock Company.

TOP